N4.187 BN PROFIT: Fidson reaffirms leadership in pharma sector


By Chioma Obinna

FIDSON  Healthcare Plc last week reaffirmed its commitments in the pharmaceutical sector, as its shareholders will receive a dividend of 55 kobo per share for the year ended December 31, 2022.

The shareholders unanimously approved this at its 24th Annual General Meeting in Lagos, disclosing that the dividend represents a 10 percent increase, an improvement on the 50 kobo per share paid in the 2021 financial year.

Fidson is expanding its pharmaceutical production capacity to meet Nigeria’s growing demand for critical therapeutic area drugs as well as other West African countries.

Fidson also reported a turnover of  N40.634 billion for the year ended December 31, 2022, representing a 31.7 percent increase compared to the N30.861 billion revenue in 2021.

Speaking, the Founder and Managing Director of Fidson Healthcare Plc., Dr. Fidelis Ayebae, attributed the impressive performance of the company to the sustained support, trust, and interest of the…

Source: Vanguard Newspaper